Amprenavir

氨普那韦

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameAmprenavir
Drug Alias Nameamprenavir安普那韦安泼那韦Amprenavirum安瑞那韦 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/04/15
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgGlaxo Wellcome IncGlaxosmithkline Plc +[5] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeJ05AE05
Related LinksWikipediaDrugBankKEGG